/ -- Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, a generic version of Vytorin[1] Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, and 10 mg/80 mg, of MSD International GmbH.
(Logo: https://bsmedia.business-standard.commma.prnewswire.com/media/451507/PRNE_Glenmark_Logo.jpg)
[2]Market includes brand and all available therapeutic equivalents
*IQVIA National Sales Perspectives: Retail & Non-Retail, April 2019
About Glenmark Pharmaceuticals